98%
921
2 minutes
20
Background: Wastewater surveillance (WS) technology has gained significant attention in many countries due to its role in the monitoring of infectious diseases within communities and complementing clinical testing to prevent coronavirus disease 2019 (COVID-19) outbreaks. In 2023, the Korea Disease Control and Prevention Agency (KDCA) launched the Korea Wastewater Surveillance (KOWAS) project in collaboration with 17 cities and provinces to track COVID-19 outbreaks.
Methods: From January to August 2023, the concentrations of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) E gene in wastewater were monitored in 19 institutes of health and environmental research, all within local governments. Influent samples were collected from 62 wastewater treatment plants (WWTPs) and weekly trends in SARS-CoV-2 E gene concentrations in wastewater were compared to those of new COVID-19 cases.
Results: During 34 weeks, the concentration of SARS-CoV-2 in wastewater samples closely mirrored the trends in new COVID-19 cases, showing the effectiveness of WS in detecting the presence of the virus. However, the efficacy of the WS method varied between provinces. Although some provinces showed a significant positive correlation between new COVID-19 cases and SARS-CoV-2 E gene concentrations in wastewater, this correlation was inconsistent between all locations. However, when data were analyzed on a broader regional scale, defined as a grouping of multiple provinces, a higher proportion of regions showed significant correlations. This suggests that analyzing WS data on a broader scale, with larger aggregated populations and higher coverage rates, reduces the influence of local variabilities, such as the proportion of combined sewer types, WWTPs coverage rate, and foot traffic, which may affect alignment at the provincial level.
Conclusion: The synchrony between trends in SARS-CoV-2 E gene concentrations in wastewater and new COVID-19 cases highlights the effectiveness of KOWAS in tracking new clinical cases. However, measured SARS-CoV-2 RNA concentrations can be affected by socioenvironmental factors (e.g., WWTP treatment capacity, sewer pipeline distances, and coverage populations). Further refinement will involve expanding the surveillance network to include additional WWTPs and a more comprehensive range of monitoring targets.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12322592 | PMC |
http://dx.doi.org/10.3346/jkms.2025.40.e94 | DOI Listing |
Microbiol Spectr
September 2025
Laboratoy of Virology, Microbiology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
Millions of reverse transcription-polymerase chain reaction (RT-PCR) tests have been performed worldwide during the SARS-CoV-2 pandemic, using various protocols. This study evaluates the duration of SARS-CoV-2 RNA detectability by RT-PCR at body temperature and analyzes changes in cycle threshold (Ct) values over time. Positive nasopharyngeal swabs for SARS-CoV-2 RT-PCR ( = 120) with different Ct values were collected from Hospital Universitario 12 de Octubre (Madrid, Spain, 2020).
View Article and Find Full Text PDFInt J Endocrinol
August 2025
Department of Geriatrics, Zhongshan Hospital Xiamen University, School of Medicine, Xiamen University, Xiamen 361000, Fujian, China.
Osteoporosis is a progressive bone disease characterized by reduced bone density and deterioration of bone microarchitecture, predominantly affecting the elderly population. The ongoing COVID-19 pandemic has introduced additional challenges in osteoporosis management, potentially due to systemic inflammation and direct viral impacts on bone metabolism. This study aims to identify common differentially expressed genes (DEGs) and key molecular pathways shared between osteoporosis and COVID-19, with the goal of uncovering potential therapeutic targets through bioinformatics analysis.
View Article and Find Full Text PDFFront Immunol
September 2025
Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Parque Tecnológico de Ciencias de la Salud (PTS), Granada, Spain.
Introduction: The COVID-19 pandemic had significant global public health consequences, affecting over 200 countries and regions by 2020. The development and efficacy of specific vaccines, such as the mRNA-1273 (Spikevax) vaccine developed by Moderna Inc., have substantially reduced the impact of the pandemic and mitigated its consequences.
View Article and Find Full Text PDFJ Virol Methods
September 2025
Laboratorio de Virología, Facultad de Ciencias Veterinarias, Universidad Nacional de La Plata, Buenos Aires, Argentina. 60 y 118, La Plata (CP 1900), Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Godoy Cruz 2290, CABA, Argentina. Electronic address
The global emergence of SARS-CoV-2 has highlighted the need for rapid, sensitive, and affordable diagnostic tools, not only for human health but also for animal surveillance within a One Health framework. This study aimed to evaluate the performance of a SYBR Green-based real-time quantitative PCR (qPCR) assay for the detection of SARS-CoV-2 from animal samples, focusing on domestic dogs and cats. A total of 140 oropharyngeal swab samples were collected and analyzed using primers targeting a 139-bp fragment of the N gene of SARS-CoV-2.
View Article and Find Full Text PDFAutoimmunity
December 2025
Medicinal Genomics, Beverly, MA, USA.
For some of the COVID-19 vaccines, the drug substances released to market were manufactured differently than those used in clinical trials. Manufacturing nucleoside-modified mRNA (modRNA) for commercial COVID-19 vaccines relies on RNA polymerase transcription of a plasmid DNA template. Previous studies identified high levels of plasmid DNA in vials of modRNA vaccines, suggesting that the removal of residual DNA template is problematic.
View Article and Find Full Text PDF